Drug intelligence / Profile preview

tetryzoline

Development stage
Phase 3
Modality
Small Molecules
Administration
Ophthalmic, Intranasal
01

Overview

Tetryzoline, also known as tetrahydrozoline, is a sympathomimetic amine and selective alpha-adrenoceptor agonist used primarily as an ocular and nasal decongestant. It acts by stimulating alpha‑1 adrenergic receptors in the arterioles of the conjunctiva and nasal mucosa, leading to vasoconstriction. This mechanism reduces redness and swelling in the eyes caused by minor irritants (such as dust, smoke, or pollen) and relieves nasal congestion. Tetryzoline is available over-the-counter in eye drops (notably under brands like Visine) for temporary relief of eye redness and irritation, as well as in some nasal sprays (e.g., Tyzine). It may be combined with other agents such as lubricants or antihistamines for enhanced effect. The drug can cross the blood-brain barrier; systemic absorption may cause central nervous system effects including sedation at high doses[1][5][7].

Brand names
VisineTyzineAltazineOptigene 3Optigene3Optigene-3Geneye ExtraGeneyes
Other names
tetrahydrozoline hydrochloride
02

Targets

ADRA2A (α2A)ADRA1A (α1A)

Beyond the preview

Go deeper on tetryzoline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tetryzoline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call